CDEK
← Mechanisms of action

Lipopolysaccharide (LPS)

MACROMOLECULEBacteria

Drugs acting on this target (12)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
T88AdccexperimentalmAbLipopolysaccharide (LPS) adcc
pl-18AntagonistexperimentalPeptideLipopolysaccharide (LPS) antagonist
j5-omp vaccineImmunity, activeexperimentalVaccineLipopolysaccharide (LPS) immunity, active
septomonabImmunity, passiveexperimentalmAbLipopolysaccharide (LPS) immunity, passive
ar101 (Aerumab)InhibitorexperimentalmAbLipopolysaccharide (LPS) inhibitor
edobacomabInhibitorexperimentalmAbLipopolysaccharide (LPS) inhibitor
kbpa-101InhibitorexperimentalmAbLipopolysaccharide (LPS) inhibitor
septomonabInhibitorexperimentalmAbLipopolysaccharide (LPS) inhibitor
taurolidine (Defencath)InhibitorexperimentalSmall moleculeLipopolysaccharide (LPS) inhibitor
UplegananInhibitorexperimentalSmall moleculeLipopolysaccharide (LPS) inhibitor
edobacomabOtherexperimentalmAbLipopolysaccharide (LPS) other
opebacanSequestering agentexperimentalRecombinant proteinLipopolysaccharide (LPS) sequestering agent